ES2133734T3 - Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente. - Google Patents

Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente.

Info

Publication number
ES2133734T3
ES2133734T3 ES95908436T ES95908436T ES2133734T3 ES 2133734 T3 ES2133734 T3 ES 2133734T3 ES 95908436 T ES95908436 T ES 95908436T ES 95908436 T ES95908436 T ES 95908436T ES 2133734 T3 ES2133734 T3 ES 2133734T3
Authority
ES
Spain
Prior art keywords
polytiourea
pharmaceutical formulations
use procedure
formulations including
appropriate use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95908436T
Other languages
English (en)
Inventor
Michael J Mullins
William A Fordyce
William J Kruper
Norton P Peet
Alan D Cardin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc, Dow Chemical Co filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2133734T3 publication Critical patent/ES2133734T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LOS OLIGOMEROS DE LA PRESENTE INVENCION SON POLITIOUREAS QUE TIENEN DE 3 A 50 UNIDADES PERIODICAS DERIVADAS DE DIAMINAS AROMATICAS SUBSTITUIDAS CON GRUPOS ANIONICOS, Y QUE TIENEN UN NUMERO DE PESO MOLECULAR MEDIO MENOR DE 10.000.ESTOS OLIGOMEROS SON SOLUBLES EN AGUA, PREFERIBLEMENTE TIENEN UNA COLUMNA VERTEBRAL RIGIDA Y SON FARMACEUTICAMENTE ACEPTABLES.LOS ALIGOMEROS SON UTILES PARA EL TRATAMIENTO Y/O DIAGNOSTICO DEL SIDA.
ES95908436T 1994-01-03 1995-01-03 Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente. Expired - Lifetime ES2133734T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17658694A 1994-01-03 1994-01-03

Publications (1)

Publication Number Publication Date
ES2133734T3 true ES2133734T3 (es) 1999-09-16

Family

ID=22644965

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95908436T Expired - Lifetime ES2133734T3 (es) 1994-01-03 1995-01-03 Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente.

Country Status (23)

Country Link
US (1) US6086864A (es)
EP (1) EP0738261B1 (es)
KR (1) KR100362343B1 (es)
CN (1) CN1070180C (es)
AP (1) AP638A (es)
AT (1) ATE178595T1 (es)
AU (1) AU693853B2 (es)
CA (1) CA2179988C (es)
CZ (1) CZ197996A3 (es)
DE (1) DE69508913T2 (es)
DK (1) DK0738261T3 (es)
ES (1) ES2133734T3 (es)
FI (1) FI962725A0 (es)
GR (1) GR3030521T3 (es)
HU (1) HUT74694A (es)
IL (1) IL112174A (es)
MX (1) MX9602542A (es)
NO (1) NO306613B1 (es)
NZ (1) NZ279587A (es)
OA (1) OA10367A (es)
TW (1) TW303377B (es)
WO (1) WO1995018791A1 (es)
ZA (1) ZA9410408B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid
CN105582020B (zh) * 2014-10-21 2019-04-16 浙江大学 一种线形聚硫脲和超支化聚硫脲在制备抗肿瘤药物及抗病毒或抗菌药物中的应用
CN107236128A (zh) * 2017-06-21 2017-10-10 华南理工大学 一种异腈、硫和胺的多组分聚合制备聚硫脲的方法及该聚硫脲的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544868A (es) *
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
US2868834A (en) * 1955-02-01 1959-01-13 Ciba Pharm Prod Inc Manufacture of new polythioureas
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
DE69318136T2 (de) * 1992-02-20 1998-10-22 Merrell Dow Pharma Sulfonsaeurederivate zur behandlung von viruserkrankungen

Also Published As

Publication number Publication date
GR3030521T3 (en) 1999-10-29
AP9600842A0 (en) 1996-07-31
NO962782L (no) 1996-09-02
CA2179988C (en) 2002-10-29
OA10367A (en) 2001-11-19
WO1995018791A1 (en) 1995-07-13
IL112174A (en) 1999-05-09
AP638A (en) 1998-04-14
DE69508913D1 (de) 1999-05-12
CN1138323A (zh) 1996-12-18
FI962725A (fi) 1995-07-02
AU693853B2 (en) 1998-07-09
US6086864A (en) 2000-07-11
NZ279587A (en) 1997-04-24
FI962725A0 (fi) 1996-07-02
HUT74694A (en) 1997-01-28
AU1675695A (en) 1995-08-01
CN1070180C (zh) 2001-08-29
DE69508913T2 (de) 1999-12-02
NO962782D0 (no) 1996-07-02
HU9601813D0 (en) 1996-09-30
KR100362343B1 (ko) 2003-11-28
CZ197996A3 (en) 1996-12-11
EP0738261A1 (en) 1996-10-23
IL112174A0 (en) 1995-03-15
NO306613B1 (no) 1999-11-29
EP0738261B1 (en) 1999-04-07
ZA9410408B (en) 1995-12-11
MX9602542A (es) 1997-05-31
ATE178595T1 (de) 1999-04-15
CA2179988A1 (en) 1995-07-13
TW303377B (es) 1997-04-21
DK0738261T3 (da) 1999-10-18

Similar Documents

Publication Publication Date Title
ES2124695T3 (es) Oligomeros, sus aplicaciones y formulaciones.
HUP0003323A2 (hu) Vorikonazolt tartalmazó gyógyászati készítmények
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
GT199800046A (es) Compuestos de pirazina.
DE10299003I2 (de) Phosphatbindende Polymere f}r orale Verabreichung
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR009089A1 (es) Composiciones para el cuidado del color que comprenden un agente fijador de colorante y un polimero y un metodo para proporcionar cuidado de color
ES2180279T3 (es) Compuesto de hierro-dextrano para utilizacion como componente en composicion terapeutica para profilaxis o tratamiento de deficiencia de hierro, procedimiento para su produccion y utilizacion del mismo para preparacion de composicion terapeutica administrable por via parenteral.
MX9308005A (es) Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
DK0998287T3 (da) Anvendelse af levobupivacain
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
ES2164447T3 (es) Procedimiento de inhibicion de resorcion del hueso.
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
ES2099962T3 (es) Oligomeros que inhiben la proliferacion.
ES2133734T3 (es) Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente.
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
HUP0105351A2 (hu) Pezsgő hashajtó készítmények és alkalmazásuk
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2073180T3 (es) Vacuna adecuada para combatir la bacteria bordetella pertussis.
BR9809504A (pt) Utilização de uma heparina de baixo peso molecular
PE37498A1 (es) Composiciones para la prevencion y tratamiento de trastornos gastrointestinales
ES2072005T3 (es) Utilizacion de analogos de 20(r)-22-oxa-vitamina d en la preparacion de un medicamento para el tratamiento del envejecimiento de la piel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 738261

Country of ref document: ES